Entocort EC

Entocort EC is a brand name of budesonide, approved by the FDA in the following formulation(s):

ENTOCORT EC (budesonide - capsule; oral)

• 
  Manufacturer: ASTRAZENECA
  
  Approval date: October 2, 2001
  
  Strength(s): 3MG ^[RLD][AB]

Has a generic version of Entocort EC been approved?

A generic version of Entocort EC has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Entocort EC and have been approved by the FDA:

budesonide capsule; oral

• 
  Manufacturer: MYLAN
  
  Approval date: May 16, 2011
  
  Strength(s): 3MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Entocort EC. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Oral composition for the treatment of inflammatory bowel disease
  Patent 5,643,602
  Issued: July 1, 1997
  Inventor(s): Ulmius; Jan
  Assignee(s): Astra Aktiebolag
  An oral pharmaceutical composition is described for targeted slow release in the treatment of inflammatory bowel diseases. Also described are pharmaceutical compositions for peroral treatment targeted to different areas of the intestinal tract afflicted by ulcerative colitis and certain aspects of Crohn's disease.
  
  Patent expiration dates:
  
  
  • July 1, 2014
    
    ✓ 
    Patent use: TREATMENT OF MILD TO MODERATE ACTIVE CHROHN'S DISEASE INVOLVING THE ILEUM AND/OR THE ASCENDING COLON AND THE MAINTENANCE OF CLINICAL REMISSION OF MILD TO MODERATE CROHN'S DISEASE INVOLVING THE ILEUM AND/OR ASCENDING COLON FOR UP TO 3 MONTHS
  
  
  
  • January 1, 2015
    
    ✓ 
    Pediatric exclusivity
    ✓ 
    Drug product
  
  

See also...

• Entocort EC Sustained-Release Capsules Consumer Information (Wolters Kluwer)
• Entocort EC Consumer Information (Cerner Multum)
• Entocort EC Advanced Consumer Information (Micromedex)
• Budesonide Powder Consumer Information (Wolters Kluwer)
• Budesonide Suspension Consumer Information (Wolters Kluwer)
• Budesonide Sustained-Release Capsules Consumer Information (Wolters Kluwer)
• Budesonide Consumer Information (Cerner Multum)
• Budesonide inhalation Consumer Information (Cerner Multum)
• Pulmicort Spacer Advanced Consumer Information (Micromedex)
• Rhinocort Turbuhaler Advanced Consumer Information (Micromedex)
• Budesonide Advanced Consumer Information (Micromedex)
• Budesonide Inhalation Advanced Consumer Information (Micromedex)
• Budesonide AHFS DI Monographs (ASHP)